Ultrasound in neurolymphomatosis
The rise of the machines Electrodiagnosis (EMG and nerve conduction studies) has long occupied an enviable position in neurology as the sole technology with which the practitioner could routinely evaluate neuromuscular disease. Its hegemony is now being called into question. For those who like diagnosing patients without the assistance of consultants, ultrasound proves to be the optimal new technique. MRI, a radiology alternative, comes in a distant second. In this issue of Neurology ® , Vijayan et al. 1 provide evidence to support the use of neuromuscular ultrasound for the diagnosis of neurolymphomatosis. The article is of particular interest because it highlights the value of color Doppler, one of several useful ultrasound technologies available on current instruments, in nerve imaging. Neurolymphomatosis is a rare but potentially treatable manifestation of non-Hodgkin lymphoma. 1 It is difficult to diagnose even when causing a focal neuropathy or diffuse polyneuropathy in someone with known lymphoma, because the findings can be ascribed to positioning, radiation, or chemotherapy. Even more challenging is the diagnosis of neurolymphomatosis when it is the presenting symptom of lymphoma.
The investigators show us several expected findings in the 3 patients they describe. 1 First, the affected nerve segments show enlargement with disturbance in the normal fascicular architecture. These are nonspecific findings common to entrapments, tumors, and inflammatory neuropathies. Second, the enlargement is focal. This helps to distinguish the finding from the more diffuse enlargement seen in hereditary demyelinating neuropathies. 2 Third, ultrasound helps to guide selective biopsy of involved nerve segments. Striking and unexpected, however, is the fourth finding: markedly increased blood flow on color Doppler imaging of the enlarged nerves. The application of Doppler blood flow imaging for the study of nerve pathology is relatively new and its value as a potential biomarker is being explored.
1,3-5 Modest increases in blood flow are sometimes found in entrapment and inflammatory neuropathies, but such findings are subtle compared to the magnitude observed in these patients. 3, 4 Lepromatous neuropathy, in inflammatory stages, may show a high degree of increased blood flow in nerves, 5 but outside of endemic areas it is unlikely to be confused with neurolymphomatosis.
What the study cannot address, because of the small numbers reported, is the yield of screening for neurolymphomatosis with ultrasound and the extent to which these findings are typical of this disorder. If the findings are confirmed in subsequent case series, then it may be possible to design larger studies to provide more definitive evidence of its value.
What does this article teach us? Probably the most important message is that those of us who practice clinical neurophysiology need to take full advantage of ultrasound. Whereas cross-sectional area measurements give clinicians a reliable handle on nerve enlargement, ultrasound can provide several other useful types of information; this report demonstrates the importance of color Doppler nerve imaging. 1 Even more precise information about nerve and muscle blood flow can be obtained from contrast ultrasound and studies are just beginning to explore this technology. 6 Elastography, which can be considered a form of acoustic palpation, is an ultrasound modality that provides information about the relative stiffness of tissue, and shows promise for identifying nerve and muscle pathology. 7 Although discovered long before nerve ultrasound, muscle ultrasound also has the potential for adding additional information. Muscle thickness is a good biomarker of clinical atrophy and is a sensitive measure that correlates closely with compound motor action potentials. 8 As muscles undergo neurogenic and myopathic changes, echogenicity of the muscle increases. One recent study has highlighted the value of comparing thenar and hypothenar echointensity as a sensitive marker of entrapment neuropathy. 9 Finally, dynamic studies of muscle can demonstrate fasciculations and, to a lesser extent, fibrillations in muscle, aspects of physiology previously thought to be solely in the province of needle EMG. 10 Ultrasound and electrodiagnosis are clearly complementary techniques. Both localize lesions. Electrodiagnosis studies often localize pathology to a segment of a nerve, whereas ultrasound can precisely demarcate the anatomic boundaries of an abnormality. Furthermore, ultrasound, by visualizing nearby structures and vascularity, can be more informative regarding etiology. Electrodiagnostic testing seems superior to ultrasound in evaluating severity and duration of nerve injury, but such information is often available through an accurate patient interview. Finally, whereas vacuum tube technology found in instruments 50 years ago is still adequate for even sophisticated electrodiagnosis studies, ultrasound technology continues to evolve. The message is clear: a new kind of machine has risen with powerful and advanced applications. It is time for neurologists to adapt, adopt, and integrate neuromuscular ultrasound into their practice of electrodiagnostic medicine.
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